|
|
|
|
Science Sparks @ ACTREC
|
 29th July 2024 |
Vol. No. 13 ; Issue No.641 |
|
|
Publications
|
|
1. Mohanty SK, Wadasadawala T, Sen S, Maiti S, Jishna E. Catastrophic health expenditure and distress financing of breast cancer treatment in India: evidence from a longitudinal cohort study. International Journal for Equity in Health. 23(1):145.
2. König C, Ivanisenko N, Hillert-Richter L, Namjoshi D, Natu K, Espe J, Reinhold D, Kolchanov N, Ivanisenko V, Kähne T, Bose K, Lavrik I (2024). Targeting type I DED interactions at the DED filament serves as a sensitive switch for cell fate decisions. Cell Chemical Biology.
3. Chopra S, Bosse T, Horeweg N, Deodhar K, Menon S, Rafael T, Pai V, Rijstenberg L, Kemenade F, Kannan S, Mahantshetty U, Segedin B, Huang F, Bruheim K, Perez M, Rai B, Tan L, Giannakopoulus N, Schmid M, Tanderup K, Pötter R, Nout R (2024). Biomarker expression and impact on clinical outcomes in an international study of chemoradiation and MRI-based image-guided brachytherapy for locally advanced cervical cancer: BIOEMBRACE. International Journal of Radiation Oncology, Biology, Physics.
4. Chakrabarty N, Mahajan A, Basu S, D'Cruz AK (2024). Imaging recommendations for diagnosis and management of primary parathyroid pathologies: A comprehensive review. Cancers (Basel). 16(14):2593.
5. Gandhi KA, Shirsat A, Hj SK, Chavan A, Dicholkar P, Shah S, Menon N, Noronha V, Joshi A, Prabhash K, Patil V, Gota V (2024). Pharmacokinetics and clinical outcomes of low-dose nivolumab relative to conventional dose in patients with advanced cancer. Cancer Chemotherapy and Pharmacology.
6. Shakthi Devan R K, Ingle A, Ramachandra SG, Hegde N, Ramesh S, Nagarajan P, Muthukumar SP, Buragohain R, Singh V, Tamhankar C (2024). Advancements of 3Rs in biomedical research, laboratory animal science and welfare: International perspectives. Journal of Laboratory Animal Science. 7(2): 74-96.
|
|
|
|
|
Interesting Reads
|
|
Blakely CM, Urisman A, Gubens MA, Mulvey CK, Allen GM, Shiboski SC, Rotow JK, Chakrabarti T, Kerr DL, Aredo JV, Bacaltos B, Gee M, Tan L, Jones KD, Devine WP, Doebele RC, Aisner DL, Patil T, Schenk EL, Bivona TG, Riess JW, Coleman M, Kratz JR, Jablons DM (2024). Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study. Journal of Clinical Oncology.
|
|
|
Video of the Week
|
|
| Extracellular Vesicles as Communicators Between Cells - A Role in Cancer Dissemination |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In 2009, Researchers found that immunotherapy improves cure rates for children with neuroblastoma.
|
|
|
|
|
|
2024 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
